<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/adpt" ></link>
<id>urn:uuid:9c659e1c-30f4-58d2-bb00-b93d8648d273</id>
<updated>2026-11-05T02:01:09-05:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR,COO) Sold (AS) 23,762 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $25.23-$26.34 on 10/30-11/2</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6487109" ></link>
<id>urn:uuid:160659cc-6f49-c320-1a34-0e90bc4ee093</id>
<updated>2026-11-03T19:51:58-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $26.64. Mkt Cap:4.3B. 10D Vol: 1.9mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR,COO) Exercised 35,643 Options (OE*) of ADAPTIVE BIOTECHNOLOGIES CORP for $12.14 on 10/30-11/3, and Kept Some</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6487111" ></link>
<id>urn:uuid:0fd659ea-9e89-dd60-2200-96f11437d789</id>
<updated>2026-11-03T19:51:58-05:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $26.64. Mkt Cap:4.3B. 10D Vol: 1.9mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR,COO) Exercised 35,643 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $12.14 on 10/27-10/29, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6485250" ></link>
<id>urn:uuid:2a244028-815b-0417-e73b-d190a61c8f8a</id>
<updated>2026-10-29T19:52:48-04:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $26.64. Mkt Cap:4.3B. 10D Vol: 1.9mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR,COO) Exercised 35,643 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $12.14 on 10/22-10/26, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6484116" ></link>
<id>urn:uuid:b11ea645-a183-b4ed-f20a-f2ef0bdf1d37</id>
<updated>2026-10-26T18:52:33-04:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $26.64. Mkt Cap:4.3B. 10D Vol: 1.9mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR,COO) Exercised 35,643 Options (OE) of ADAPTIVE BIOTECHNOLOGIES CORP for $12.14 on 10/19-10/21, and Sold Them All</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6483160" ></link>
<id>urn:uuid:4858953e-0356-1c3b-e74f-5f0c221044b5</id>
<updated>2026-10-21T18:36:06-04:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $26.64. Mkt Cap:4.3B. 10D Vol: 1.9mm]]></summary>
</entry>
<entry>
<title>ADPT: RUBINSTEIN JULIE (PR,COO) Sold (AS) 23,762 Shares of ADAPTIVE BIOTECHNOLOGIES CORP for $25.57-$25.61 on 10/14-10/15</title>
<link href="http://www.insiderinsights.com/company/adpt/adaptive-biotechnologies-corp/id-6481994" ></link>
<id>urn:uuid:c4a91e74-9b8a-5ab7-f36d-25a47021bfed</id>
<updated>2026-10-16T19:21:32-04:00</updated>
<summary type="html" ><![CDATA[ADAPTIVE BIOTECHNOLOGIES CORP (ADPT). Recent Price: $26.64. Mkt Cap:4.3B. 10D Vol: 1.9mm]]></summary>
</entry>
</feed>